Evidence map›Paper›PMID 35325446›Full record

ArticleJournal of endocrinological investigation2022

Differences in cardiometabolic risk profiles between Chinese and Finnish older adults with glucose impairment and central obesity.

S Le, Y Zhang, A Voutilainen, X Tan, J Laukkanen, C Wang, S Cheng

Open access · hybridAbstract read
In one paragraph

Article in Journal of endocrinological investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

S LeExercise Translational Medicine Center, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, 200240, Shanghai, China.
Y ZhangShanghai Jiao Tong University Affiliated Sixth People's Hospital, The Metabolic Disease Biobank, Shanghai, 200233, China.
A VoutilainenInstitute of Public Health and Clinical Nutrition, University of Eastern Finland, 70211, Kuopio, Finland.
X TanExercise Translational Medicine Center, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, 200240, Shanghai, China.
J Laukkanen *Faculty of Sport and Health Sciences, University of Jyväskylä, 40014, Jyväskylä, Finland. jariantero.laukkanen@uef.fi.
C Wang *Department of Endocrinology and Metabolism, School of Medicine, Shanghai Fourth People's Hospital Affiliated to Tongji University, Tongji University, 1279 Sanmen Road, Shanghai, 200434, China. crwang@tongji.edu.cn.
S Cheng *Exercise Translational Medicine Center, Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, 200240, Shanghai, China. shulin.cheng@jyu.fi.ORCID http://orcid.org/0000-0001-9601-4834
Shanghai Jiao Tong University · CNUniversity of Eastern Finland · FIHubei University of Medicine · CNTongji University · CNUppsala University · SE

Funding

National Natural Science Foundation of China 81770883National Natural Science Foundation of China 82070913Research Start-up Fund from Shanghai Fourth People's Hospital sykyqd01801Shanghai Science and Technology Development Foundation 20ZR1446000
6 · The paper itself

Abstract

backgroundObesity and ethnicity play important roles in cardiovascular complications in patients with type 2 diabetes mellitus (T2DM). This study aimed to compare cardiometabolic risk profiles between Chinese and Finnish older adults of central obesity with prediabetes or T2DM.

methodsStudy subjects were 60-74 years old and originated from two population samples. The Finnish subjects came from the Kuopio Ischemic Heart Disease (KIHD) study (n = 1089), and the Chinese subjects came from the Shanghai High-risk Diabetic Screen (SHiDS) study (n = 818). The KIHD and SHiDS studies used similar questionnaires to determine participants' baseline characteristics regarding the history of medication use and diseases and lifestyle factors. All study subjects participated in glucose tolerance tests and anthropometry assessments, including waist circumference measurements.

resultsAmong study subjects of central obesity with prediabetes (n = 298), fasting and 2-h glucose, and fasting insulin and insulin resistance were significantly higher in Chinese than in Finnish (p < 0.0001-0.016). In addition, triglyceride (TG) level was higher and the low-density lipoprotein cholesterol (LDL) and LDL to high-density lipoprotein cholesterol (HDL) ratio were lower in Chinese than in Finnish (p < 0.0001-0.003). Among subjects of central obesity with T2DM (n = 251), Chinese subjects had significantly less proportions of antihypertensive, glycaemic control medication, and statin users as well as lower level of physical activity (p < 0.0001 for all), while higher blood pressure (p = 0.002 for systolic blood pressure and p < 0.0001 for diastolic blood pressure), TG levels (p < 0.05) and HDL (p = 0.002) than the Finnish counterparts. There were no differences in β-cell function (HOMA-β) between Chinese and Finnish both in prediabetes and T2DM.

conclusionsOur results indicated that Chinese and Finnish older adults of central obesity with prediabetes and T2DM had similar β-cell function. However, Chinese individuals with prediabetes are prone to insulin resistance. Meanwhile, lipid metabolism dysfunction is also different between Chinese and Finnish. Chinese older adults of central obesity with prediabetes showed higher TG, but Finnish showed higher LDL and LDL/HDL. Strategic for T2DM prevention and treatment should be ethnically specific.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2Insulin ResistancePrediabetic StateAgedBlood GlucoseChinaCholesterol, HDLFinlandGlucoseHumansMiddle AgedObesityObesity, AbdominalRisk FactorsTriglyceridesBlood GlucoseCholesterol, HDLGlucoseTriglyceridesCardiovascular disease riskCentral obesityChineseEthnicityFinnishType 2 diabetes mellitus

Identifiers

PMID35325446
PMCPMC9184414
OpenAlexW4220655706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.